FDA Inspection
Muhlestein, Joseph B., M.D.Muhlestein, Joseph B., M.D. – FDA Inspection, Feb 25, 2011
Record Details
This FDA Inspection record concerns Muhlestein, Joseph B., M.D., with an inspection on February 25, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Muhlestein, Joseph B., M.D.
- Inspection Date
- February 25, 2011
- Product Type
- Drugs
View Company Profile
ID · 402c6589-5dd3-4d55-9138-4c0f7929127c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 714292
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Muhlestein, Joseph B., M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Muhlestein, Joseph B., M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.